ALLMedicine™ Liver Transplantation Center

May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.

May 15th, 2022 - It has long been debated whether cava anastomosis should be performed with the piggyback technique or cava replacement, with or without veno-venous bypass (VVB), with or without temporary portocaval shunt (PCS) in the setting of liver transplantat...

May 15th, 2022 - Twenty percent of pediatric patients with BA develop ACLF with increased mortality while awaiting LT. Respiratory complications are common in pediatric ACLF and are associated with increased morbidity and mortality. ARDS is the most severe manifes...

May 15th, 2022 - The Fibrosis-4 Index (FIB-4) can reliably assess fibrosis risk in patients with chronic liver disease and advanced fibrosis is associated with severe liver disease (SLD) outcomes. However, CLD is under-diagnosed in primary care. We examined the as...

May 15th, 2022 - Body composition predicts mortality in patients with cirrhosis. The impact of sex on this association is unknown. We investigated the impact of sex on this association in patients with cirrhosis assessed for liver transplantation. This single cent...

Aug 1st, 2021 - The field of liver transplantation directly or indirectly embodies all liver diseases, in addition to specific ones related to organ rejection (cellular and humoral). The recommended non-invasive methods for determining the indication for liver tr...

May 29th, 2021 - Donation after circulatory death (DCD) grafts are commonly used in liver transplantation. Attributable to the additional ischemic event during the donor warm ischemia time (DWIT), DCD grafts carry an increased risk for severe ischemia/reperfusion ...

May 10th, 2021 - Enhanced Recovery After Surgery (ERAS) is a multimodal, evidence-based, program of care developed to minimize the response to surgical stress, associated with reduced perioperative morbidity and hospital stay. This study presents the specific ERAS...

Mar 25th, 2021 - Recent trials in liver machine perfusion (MP) have revealed unique challenges beyond those seen in most clinical studies. Correct trial design and interpretation of data are essential to avoid drawing conclusions that may compromise patient safety...

Mar 7th, 2021 - Donation after circulatory death (DCD) donors are an increasingly more common source of livers for transplantation in many parts of the world. Events that occur during DCD liver recovery have a significant impact on the success of subsequent trans...

May 13th, 2022 - Background: Neuroendocrine tumors (NETs) of the gastrointestinal tract and pancreas are a rare and heterogeneous, but clinically important, group of neoplasms with unique tumor biology, natural history, and clinical management issues. While the tr...

May 12th, 2022 - Biliary complication is the most common complications after liver transplantation, and it happens more often after living donor liver transplantation (LDLT) than deceased donor liver transplantation. Many transplant centers adopted their own metho...

May 10th, 2022 - HYPOTHESIS: Administration of supraphysiologic doses of parenteral AA in the perioperative period for patients undergoing liver transplantation will improve Sequential Organ Failure Assessment (SOFA) scores, vasopressor usage and biochemical, cell...

May 10th, 2022 - Ventral hernia is a frequently occurring complication following liver transplantation, with a reported risk in the literature ranging from 5% to 25%. This study aims to evaluate if the risk of developing ventral hernia after liver transplantation ...

May 10th, 2022 - With the increasing shortage of available donor organs, liver transplantation from donation after circulatory death (DCD) has been established in many countries to offer a therapeutic strategy for patients with end-stage liver disease beyond stand...

May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.

May 6th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  A worldwide ...

May 5th, 2022 - This spring, global health advisories have been issued regarding an alarming — and as-yet unexplained — uptick of hepatitis in children. Currently, over 200 cases have been reported worldwide, a relatively small amount that nonetheless belies a co...

Apr 29th, 2022 - Adenovirus was detected in the blood specimens of all nine children with acute hepatitis infection identified in Alabama from October 2021 to February 2022, researchers found. The nine children were 0 to 6 years old and previously healthy, and mos...

Apr 11th, 2022 - Proton pump inhibitors (PPIs), when used for prior gastrointestinal bleeding (GIB), were associated with better survival for veterans with cirrhosis, a retrospective study found. Among more than 76,000 such patients, PPI use was associated with a ...